Myths vs facts: Helicobacter and gut health

Helicobacter pylori is a bacterium that colonizes the gastric mucosa and is strongly associated with gastritis, peptic ulcers, and gastric cancer. A common myth is that H. pylori is always detrimental to gut health. In reality, the evidence is nuanced: while infection can cause inflammation and damage in susceptible individuals, some studies suggest protective effects against esophageal diseases and allergies (hygiene hypothesis). The impact on the gut microbiome is complex – H. pylori can alter microbial composition, but whether this is harmful depends on context. Eradication therapy (antibiotics plus proton pump inhibitors) is not benign; it can disrupt the microbiome and promote antibiotic resistance. Therefore, treatment should only be considered when clearly indicated (e.g., active ulcer, high cancer risk). For asymptomatic carriers, the benefit of eradication is debated. Bottom line: H. pylori is not inherently an enemy of gut health; management should be evidence-based and individualized. The evidence is mixed – strong for gastric disease associations, but also suggestive of potential benefits in certain conditions.